Abstract

Nicotinamide adenine dinucleotide (NAD + ) is an essential cofactor controlling cell metabolism and survival. NAD + is recycled in cells at rates controlled by nicotinamide phosphoribosyl transferase (NAMPRT). The pharmacological inhibition of NAMPRT by FK866 diminishes intracellular concentration of redox couples NAD + /NADPH and NADP + /NADPH. Here we examined the quantitative relationship between inhibition of NAMPRT and superoxide-producing activity of NOX2 from PMA activated macrophage RAW 264.7 cells. Cells were treated with 10nM FK866 for 24 h showed PI staining negative and survival >80%. Superoxide (O 2 ●– ) in PMA activated cells was maximally stimulated with 100-400 ng/ml. 2-Hydroxyethidium, 2-OHE + in both supernatant and cytosolic fractions was decreased in cells pre-treated with 10nM FK866 for 24 h. This inhibition was rescued with10µM NMN co-treatment. The NOX inhibitor, VAS2870 (10-100µM) decreased O 2 ●– release although toxicity was evident. FK866 did not alter the protein expression of NOX subunits, p91phox and p47phox. HPLC analysis of FK866 treated cells showed diminished intracellular levels of NAD + and NADPH and to a lesser extent NADH, NADP + . A dose-dependent effects of FK866 (1-20nM) indicated that after 24h incubation FK866 at concentrations of 10nM led to a decrease of ~50% of NADPH (from 2.2±0.2 to 1.2±0.2 nmol/mg protein) eliciting a reduction of 2-OHE + >70%. Increasing FK to 20nM showed small effects compared to 10nM treatment. An inhibition of 50% of 2-OHE+ formation was attained with 5nM FK866 treatments indicating that NADPH EC50 for NOX2 ~1.6nmol/mg protein. These results indicate that NOX2 activity is inhibited by depletion of physiological levels of NADPH which could be highly significant in the regulation of peroxynitrite and other oxidant production.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.